Sign in
4

Changes in Ownership

Processa Pharmaceuticals, Inc. Filed Acc 0000897069-25-001561

Options or other derivatives

  • Director acquired 400,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Neal James R Director 2025-10-01 Grant or award · Restricted Stock Units +100,000 100,000 D
Neal James R Director 2025-10-01 Grant or award · Stock Options (Right to Buy) +300,000 300,000 D
Loading xslF345X05/form4.xml…